See how our funding and mentorship programme is spurring healthcare innovation across Denmark.

Lithium, the gold-standard treatment for bipolar disorder, requires ongoing blood tests that must be conducted within a precise timeframe to fine-tune each patient's dosage. Two-time BETA.05 grant recipient eLi12 offers more flexibility in timing while maintaining the precision of the traditional protocol.

MyLymphCare is an at-home solution that helps breast cancer survivors detect lymphedema as soon as possible. This chronic condition affects 20% of breast cancer survivors, causing painful swelling in the affected arm – but early detection and timely treatment can significantly reduce its impact on these survivors’ daily lives.

Dermloop was one of the first recipients of a BETA.HEALTH grant. Since completing its 'accelerator programme' the project has evolved into a software company dedicated to education and clinical management across healthcare sectors. Two years on, the app is launching in all five Danish regions – and expanding into the United States and other countries.

'Internetbehandling' brings in-demand psychological treatment online, providing more accessible and timely care to more patients – and with the same efficacy as traditional face-to-face therapy sessions. The platform provides access to online treatment material and the support of a remote therapist.

BloomBaby offers a non-invasive at-home alternative to clinic-based fertility treatments. This hormone-free device can provide vital first-line assistance to the 20% of couples worldwide who struggle with infertility – as well as solo mothers and people within the LGBTQ community on their journey to becoming parents.

The BETA.HEALTH programme offers more than funding. We provide mentorship and accelerator support that's proven to transform promising concepts into patient-facing solutions. Every BETA.HEALTH-supported project receives a customised six-month 'accelerator programme' designed to bring it closer to helping patients.

This AI-enabled technology automates the most time-consuming part of radiotherapy – treatment planning. Until now, clinicians have spent up to an hour manually marking up individual CT scans to ensure an optimal radiation dosage while minimising damage to surrounding tissues and organs. This solution generates these markups within minutes and with the same precision as manual methods.

HearWalk uses wireless sensors to capture motion-related data, which it synthesises into real-time sound stimuli to assist in motor-learning recovery for patients learning to walk after a traumatic brain injury. Sound-facilitated gait training has been shown to improve focus and treatment compliance because patients find it less monotonous than traditional gait-training methods.

From the BETA.HEALTH Academy event, 'From Research to Spin-Out: A Conversation with Cessatech,' CEO Jes Trygved
talks about the importance of finding the right partners when developing and commercialising a healthcare product, his experience with entering the United States market, and some of the lessons he's learned along the way.

BETA.HEALTH 'West' recently welcomed the 'Summer 2023' grant recipients to Aarhus for a one-day event to kick off their six-month accelerator programme. The event also provided an opportunity for them to connect with their fellow innovators, and hear from entrepreneurs who've already walked the path from idea to marketable healthcare solution.

This past autumn, BETA.HEALTH 'East' invited the seven ‘Summer 2023’ grant recipients to Egelund Slot for a two-day boot camp to kick off their six-month accelerator programme. After two intense days of presentations and workshops, the recipients have finalised their six-month project plans – and are well on their way to bringing their solutions to patients!

Novel Energy Harvester System Technology (NEST) for Intracardiac Pacemakers could pave the way to a new generation of pacemakers that charge themselves through 'motion energy'. This could eliminate the need for replacement surgery due to the finite battery life of current devices.

Since Summer 2022, 43 innovation projects have received BETA.HEALTH grants, mentorship, and accelerator support. In this video, five of these recipients talk about their experiences with the programme and how it's helped them to develop their ideas and bring them closer to helping patients.

BETA.HEALTH 'East' recently held a two-day boot camp at Egelund Castle. This event officially kicked off the 'Winter 2023' grant recipients' accelerator phase, providing important business guidance and helping the teams to develop six-month innovation roadmaps for their projects.

BETA.HEALTH and Roche have joined forces to create an industry-sponsored call for grant applications aimed at further accelerating clinical innovation in three critical areas: Early Detection, Capacity Issues and Health at Home.

BETA.HEALTH is the Danish National Innovation Platform for Future Healthcare, founded by the leading hospitals in Denmark.

"Palliationskassen" (the palliative care box) aims to make it easier for loved ones to provide end-of-life care for patients in the comfortable and familiar surroundings of their homes. The box contains instructions, medicine and other items designed to take the guesswork out of providing palliative care at home.

EchoVice streamlines the capture of transesophageal images related to percutaneous heart valve procedures by essentially acting as a 'third hand' to stabilise the ultrasound probe. This holds the probe steady while allowing the operator to rotate it to obtain the required images, resulting in shorter procedures and better-quality images.

DoseTracker is a software-enabled solution providing real-time monitoring of the radiation dose delivered to moving anatomy during radiotherapy. For over a decade, medical physicist Thomas Ravkilde – who is based at Aarhus University Hospital – has been developing tools and methods capable of delivering a high dose of radiation that can eradicate a tumor while avoiding damage to the surrounding healthy tissue.

The TOLAC App, which was conceived by obstetricians Lone Krebs at Amager and Hvidovre Hospital and Ida Näslund Thagaard at Rigshospitalet, uses data-driven software to help obstetricians, midwives and expectant parents make informed decisions regarding the safest mode of delivery after a prior caesarean section.

Dermloop, which was invented by Niels Kvorning Ternov, an MD and PhD at the University Hospital of Herlev and Gentofte, offers AI-augmented training, clinical feedback, and management of skin lesions suspicious for cancer.